eris lifesciences
Jump to
57 Results Found
  • Eris Life Consolidated March 2021 Net Sales at Rs 278.21 crore, up 11.92% Y-o-Y May 14, 2021 12:44 PM IST

    Eris Life Consolidated March 2021 Net Sales at Rs 278.21 crore, up 11.92% Y-o-Y

  • Eris Life Standalone March 2021 Net Sales at Rs 256.85 crore, up 11.32% Y-o-Y May 14, 2021 12:44 PM IST

    Eris Life Standalone March 2021 Net Sales at Rs 256.85 crore, up 11.32% Y-o-Y

  • Eris Lifesciences Q4 profit up by 21% at Rs 68 crore May 13, 2021 08:37 PM IST

    Eris Lifesciences Q4 profit up by 21% at Rs 68 crore

    The company had posted a net profit of Rs 56.2 crore for the corresponding period of the previous fiscal, Eris Lifesciences said in a regulatory filing.

  • Buy Eris Lifesciences; target of Rs 666: Prabhudas Lilladher Feb 05, 2021 08:57 PM IST

    Buy Eris Lifesciences; target of Rs 666: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 666 in its research report dated January 28, 2021.

  • Eris Life Standalone December 2020 Net Sales at Rs 287.13 crore, up 12.92% Y-o-Y Jan 29, 2021 09:22 AM IST

    Eris Life Standalone December 2020 Net Sales at Rs 287.13 crore, up 12.92% Y-o-Y

  • ChrysCapital-backed Eris Lifesciences appoints former EY partner V Krishnakumar as ED & COO Nov 18, 2020 07:30 PM IST

    ChrysCapital-backed Eris Lifesciences appoints former EY partner V Krishnakumar as ED & COO

    Moneycontrol was the first to report the key Big 4 exit on September 29, 2020.

  • Buy Eris Lifesciences; target of Rs 671: Prabhudas Lilladher Nov 06, 2020 04:39 PM IST

    Buy Eris Lifesciences; target of Rs 671: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 671 in its research report dated November 03, 2020.

  • Eris Lifesciences Q2 net profit up 16% at Rs 108 crore Nov 03, 2020 07:44 PM IST

    Eris Lifesciences Q2 net profit up 16% at Rs 108 crore

    The company had posted a net profit of Rs 92.71 crore for the corresponding period of the previous fiscal, Eris Lifesciences said in a BSE filing.

  • Gland Pharma gets Sebi approval for Rs 6,000-crore IPO, set for first listing of an Indian firm with a Chinese parent Oct 21, 2020 10:08 PM IST

    Gland Pharma gets Sebi approval for Rs 6,000-crore IPO, set for first listing of an Indian firm with a Chinese parent

    The IPO is a mixture of primary and secondary issue of shares with both China’s Fosun group and the founders of Gland Pharma due to dilute shares. Gland Pharma may look to launch the IPO in November 2020

  • ChrysCapital-backed Eris Lifesciences may get EY partner V Krishnakumar on board Sep 29, 2020 05:03 PM IST

    ChrysCapital-backed Eris Lifesciences may get EY partner V Krishnakumar on board

    Over the course of the next few months, Krishnakumar is likely to join the pharma company as an Executive Director overseeing operations

  • Buy Eris Lifesciences; target of Rs 576: Prabhudas Lilladher Aug 08, 2020 12:33 PM IST

    Buy Eris Lifesciences; target of Rs 576: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 576 in its research report dated August 05, 2020.

  • Eris Life Standalone June 2020 Net Sales at Rs 261.48 crore, down 0.32% Y-o-Y Aug 05, 2020 09:22 AM IST

    Eris Life Standalone June 2020 Net Sales at Rs 261.48 crore, down 0.32% Y-o-Y

  • Accumulate Eris Lifesciences; target of Rs 576: Prabhudas Lilladher Jun 04, 2020 01:26 PM IST

    Accumulate Eris Lifesciences; target of Rs 576: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 576 in its research report dated Jun 03, 2020.

  • Eris Life Standalone March 2020 Net Sales at Rs 230.74 crore, up 16.28% Y-o-Y Jun 03, 2020 09:48 AM IST

    Eris Life Standalone March 2020 Net Sales at Rs 230.74 crore, up 16.28% Y-o-Y

  • Eris Lifesciences Q4 profit up 4% to Rs 56 crore Jun 02, 2020 03:25 PM IST

    Eris Lifesciences Q4 profit up 4% to Rs 56 crore

    Revenue from operations stood at Rs 248.56 crore during the quarter under review as against Rs 214.82 crore in the year-ago period, it added.

  • Eris Lifesciences share price gains 5% on buyback tax relief Dec 16, 2019 02:03 PM IST

    Eris Lifesciences share price gains 5% on buyback tax relief

    The company had made a public announcement on July 5 for Buyback of its equity shares of upto 17,39,130 equity shares at a price of Rs 575 per share aggregating upto Rs 100 crore.

  • Eris Lifesciences share price up 3% on acquisition of trademark Zomelis Dec 04, 2019 03:08 PM IST

    Eris Lifesciences share price up 3% on acquisition of trademark Zomelis

    The consideration involved in this trademark acquisition is $13 million, the company said

  • Eris Lifesciences share price gains 5% after block deals of 2.1% equity Nov 25, 2019 10:32 AM IST

    Eris Lifesciences share price gains 5% after block deals of 2.1% equity

    CNBC-TV18 reports indicated that about 29 lakh shares were traded in three block deals on the BSE.

  • Accumulate Eris Lifesciences; target of Rs 459: Prabhudas Lilladher Nov 08, 2019 11:53 AM IST

    Accumulate Eris Lifesciences; target of Rs 459: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 459 in its research report dated November 07, 2019.

  • Accumulate Eris Lifesciences; target of Rs 459: Prabhudas Lilladher Jul 31, 2019 11:23 AM IST

    Accumulate Eris Lifesciences; target of Rs 459: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 459 in its research report dated July 29, 2019.

  • Eris Life Standalone June 2019 Net Sales at Rs 262.33 crore, up 15.82% Y-o-Y Jul 29, 2019 12:42 PM IST

    Eris Life Standalone June 2019 Net Sales at Rs 262.33 crore, up 15.82% Y-o-Y

  • Eris Lifesciences Q1 profit up 17.5% at Rs 84.05 crore Jul 27, 2019 06:10 PM IST

    Eris Lifesciences Q1 profit up 17.5% at Rs 84.05 crore

    Net profit was Rs 71.55 crore in the corresponding quarter a year ago, Eris Lifescinces said in a BSE filing.

  • Eris Lifesciences Q1 PAT seen up 3.6% YoY to Rs. 73.8 cr: Prabhudas Lilladher Jul 12, 2019 04:54 PM IST

    Eris Lifesciences Q1 PAT seen up 3.6% YoY to Rs. 73.8 cr: Prabhudas Lilladher

    Net Sales are expected to decrease by 5.5 percent Y-o-Y (up 12.3 percent Q-o-Q) to Rs. 237.1 crore, according to Prabhudas Lilladher.

  • Eris Life Standalone March 2019 Net Sales at Rs 198.43 crore, up 2.24% Y-o-Y May 21, 2019 04:47 PM IST

    Eris Life Standalone March 2019 Net Sales at Rs 198.43 crore, up 2.24% Y-o-Y

  • Eris Lifesciences Q4 PAT seen up 15.1% YoY to Rs. 64.2 cr: Prabhudas Lilladher Apr 12, 2019 01:09 PM IST

    Eris Lifesciences Q4 PAT seen up 15.1% YoY to Rs. 64.2 cr: Prabhudas Lilladher

    Net Sales are expected to increase by 19.7 percent Y-o-Y (up 0.6 percent Q-o-Q) to Rs. 254 crore, according to Prabhudas Lilladher.

Sections